{ "schema_version": "1.0.0", "as_of": "2026-10-09", "forecast_count": 10, "forecasts_with_assessments": 3, "forecasts": [ { "forecast_id": "SS-FC-2026-001", "version": "1.0.0", "kind": "market_outlook", "original_definition": { "forecast_id": "SS-FC-2026-001", "version": "1.0.0", "status": "unresolved", "issued_on": "2026-09-16", "prepared_on": "2026-09-16", "evidence_cutoff": "2026-09-16", "horizon_start": "2026-09-17", "horizon_end": "2027-09-16", "intended_canonical_path": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-001", "thesis": "The next sufficiently observable cohort will favor learning licenses, controlled access and co-development over outright data ownership transfers.", "mechanism": "Continuing owners can monetize or benefit from learning while retaining operational access and protecting confidential source data.", "scope": "Newly announced, subsequently human-approved transactions within the horizon; exclude historical backfill and updates to existing deals.", "supporting_transaction_ids": [ "SS-AIDT-2025-0001", "SS-AIDT-2025-0002", "SS-AIDT-2026-0004", "SS-AIDT-2026-0007" ], "assumptions": [ "Meaningful training permission can be separated from ownership.", "Public disclosure will describe enough rights to classify at least five future observations." ], "alternative": "Distressed archive sales or exclusive dataset acquisitions become the more observable transaction form.", "confidence": "moderate", "confidence_rationale": "All four opening cases fit the mechanism, but the sample is selected and small.", "confirmation": "At horizon end, at least five approved new observations have classifiable ownership terms and more than half explicitly use licenses, local learning or controlled access without a disclosed transfer of underlying data ownership.", "invalidation": "With at least five classifiable observations, half or fewer meet that test.", "unresolved": "Fewer than five observations have sufficiently clear rights. Unspecified ownership is not counted as retained ownership.", "canonical_path": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-001" }, "original_url": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-001", "issued_on": "2026-09-16", "horizon_start": "2026-09-17", "horizon_end": "2027-09-16", "observations": [ { "observation": { "observed_on": "2026-09-30", "status": "unresolved", "assessment": "Interim unresolved. OneMedNet is one conservative eligible new classifiable observation. Exclude Harell under the corrected September 15 source-stated first-disclosure treatment, GuideAI as a renewal, and pre-horizon backfill. Threshold of at least five and horizon-end majority test are not met.", "supporting_transaction_ids": [ "SS-AIDT-2026-0011", "SS-AIDT-2026-0013", "SS-AIDT-2026-0014", "SS-AIDT-2026-0009", "SS-AIDT-2026-0012" ] }, "assessment_issue": "/ai-data-transactions/outlooks/2026-09-month-end/", "evidence_cutoff": "2026-09-30" } ], "latest_assessment": "unresolved", "latest_assessed_on": "2026-09-30", "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FC-2026-002", "version": "1.0.0", "kind": "market_outlook", "original_definition": { "forecast_id": "SS-FC-2026-002", "version": "1.0.0", "status": "unresolved", "issued_on": "2026-09-16", "prepared_on": "2026-09-16", "evidence_cutoff": "2026-09-16", "horizon_start": "2026-09-17", "horizon_end": "2027-09-16", "intended_canonical_path": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-002", "thesis": "At least two unrelated industrial data owners will announce qualifying learning-rights arrangements involving manufacturing or equipment-maintenance histories.", "mechanism": "Expensive failures and repeated interventions can provide task-specific learning examples that generic public text does not reproduce.", "scope": "Manufacturing process, quality/yield, industrial equipment or maintenance corpora; exclude software-only archives, ordinary deployments and two announcements from the same owner group.", "supporting_transaction_ids": [ "SS-AIDT-2026-0007" ], "assumptions": [ "Owners can link records to interventions or outcomes.", "At least some owners can grant usable learning rights and disclose the arrangement." ], "alternative": "Learning stays internal or agreements disclose only software deployment, leaving no qualifying observable rights transaction.", "confidence": "low", "confidence_rationale": "An adjacent energy precedent supports the logic, but the approved baseline has no direct manufacturing precedent.", "confirmation": "By horizon end, two qualifying announcements within the horizon from unrelated owner groups are approved with explicit model-learning use.", "invalidation": "After a documented horizon-end sector search, fewer than two qualifying announcements are found. This misses the observable-deal prediction, not proof that private arrangements do not exist.", "unresolved": "Evidence or final sector search remains incomplete; no automatic success based on deployment announcements.", "canonical_path": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-002" }, "original_url": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-002", "issued_on": "2026-09-16", "horizon_start": "2026-09-17", "horizon_end": "2027-09-16", "observations": [ { "observation": { "observed_on": "2026-09-30", "status": "unresolved", "assessment": "Interim unresolved. Zero qualifying approved manufacturing or equipment-maintenance arrangements from unrelated owner groups in this snapshot. No horizon-end sector search has occurred; do not infer failure or absence of private deals.", "supporting_transaction_ids": [ "SS-AIDT-2026-0011", "SS-AIDT-2026-0013", "SS-AIDT-2026-0014", "SS-AIDT-2026-0009", "SS-AIDT-2026-0012" ] }, "assessment_issue": "/ai-data-transactions/outlooks/2026-09-month-end/", "evidence_cutoff": "2026-09-30" } ], "latest_assessment": "unresolved", "latest_assessed_on": "2026-09-30", "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FC-2026-003", "version": "1.0.0", "kind": "market_outlook", "original_definition": { "forecast_id": "SS-FC-2026-003", "version": "1.0.0", "status": "unresolved", "issued_on": "2026-09-16", "prepared_on": "2026-09-16", "evidence_cutoff": "2026-09-16", "horizon_start": "2026-09-17", "horizon_end": "2027-09-16", "intended_canonical_path": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-003", "thesis": "At least one newly announced transaction will disclose consideration specifically allocated to proprietary corporate data learning rights, adding a pricing reference beyond Tempus.", "mechanism": "Explicit licenses create payment obligations that may appear in filings or transaction announcements even when larger programs bundle services and compute.", "scope": "A new owner/buyer arrangement announced within the horizon; disclosed amount, currency, consideration scope and payment form must be distinguishable. No minimum dollar threshold.", "supporting_transaction_ids": [ "SS-AIDT-2025-0002", "SS-AIDT-2026-0007" ], "assumptions": [ "Some counterparties disclose the license leg separately.", "A monetary allocation reflects a data right rather than merely a total program budget." ], "alternative": "Material rights remain hidden inside co-development, equity or service agreements without separate pricing.", "confidence": "low", "confidence_rationale": "One clear historical allocation establishes possibility, not its future frequency or price level.", "confirmation": "At least one approved transaction meeting scope is supported by a filing, contract or company disclosure before horizon end.", "invalidation": "No such transaction is found after a documented horizon-end pricing search. A bundled headline or pending bid does not satisfy the test.", "unresolved": "Source access or final search is incomplete. A subsequently discovered pre-horizon deal is historical backfill and cannot count.", "canonical_path": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-003" }, "original_url": "/ai-data-transactions/outlooks/2026-09-baseline/#ss-fc-2026-003", "issued_on": "2026-09-16", "horizon_start": "2026-09-17", "horizon_end": "2027-09-16", "observations": [ { "observation": { "observed_on": "2026-09-30", "status": "unresolved", "assessment": "Interim unresolved. OneMedNet supplies directional support for separately material data-license consideration but the reviewed release does not state explicit currency or settlement form. Do not add a new exact-price or named-buyer requirement: neither is stated in the original forecast. Silencio and Tempus–Recursion are excluded pre-horizon/historical arrangements.", "supporting_transaction_ids": [ "SS-AIDT-2026-0011", "SS-AIDT-2026-0013", "SS-AIDT-2026-0014", "SS-AIDT-2026-0009", "SS-AIDT-2026-0012" ] }, "assessment_issue": "/ai-data-transactions/outlooks/2026-09-month-end/", "evidence_cutoff": "2026-09-30" } ], "latest_assessment": "unresolved", "latest_assessed_on": "2026-09-30", "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FVC-2026-001", "version": "1.0.0", "kind": "frontier_value_capture", "original_definition": { "forecast_id": "SS-FVC-2026-001", "status": "unresolved", "scope": "New human-reviewed canonical AI Access records announced after the evidence cutoff and involving OpenAI, Anthropic, Google/DeepMind, Meta, xAI, or another provider operating frontier general-purpose models.", "thesis": "Non-token value capture becomes a repeatable frontier-lab business model rather than an isolated GPT-Synopsys structure.", "mechanism": "When model inference cost is small relative to measurable customer surplus, frontier labs have an incentive to exchange model capability and compute for participation in downstream economics instead of charging only for tokens or seats.", "confirmation": "By 2027-10-02, at least three new qualifying frontier-lab arrangements across at least two industries disclose Stage 3 or Stage 4 economics, and at least one reaches Stage 4.", "invalidation": "After a documented horizon-end search, fewer than three qualifying arrangements meet Stage 3 or Stage 4, or all disclosed frontier-lab arrangements remain Stage 0-2.", "confidence": "moderate", "confidence_rationale": "GPT-Synopsys is a strong Stage 4 anchor and the broader registry already contains multiple Stage 3 ecosystem precedents, but the sample contains only one clear frontier-lab shared-product structure.", "supporting_record_ids": [ "SS-AIDT-2026-0016", "SS-AIDT-2026-0011", "SS-AIDT-2026-0014" ], "outcome_observations": [], "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02" }, "original_url": "/ai-data-transactions/outlooks/frontier-value-capture/#ss-fvc-2026-001", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "observations": [], "latest_assessment": "unresolved", "latest_assessed_on": null, "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FVC-IND-2026-001", "version": "1.0.0", "kind": "industry_prediction", "original_definition": { "prediction_id": "SS-FVC-IND-2026-001", "status": "unresolved", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "industry_id": "engineering-design-simulation", "industry": "Semiconductor design, engineering simulation, and digital twins", "forecast": "This is the strongest near-term candidate for additional Stage 3-4 structures because economic outcomes are high value and unusually measurable through deterministic design, simulation, verification, and manufacturing constraints.", "confirmation": "At least one new Stage 3-4 frontier-lab arrangement beyond the existing OpenAI-Synopsys deal is announced in this industry during the horizon.", "invalidation": "No additional Stage 3-4 arrangement is found after a documented horizon-end sector search.", "confidence": "moderate_high", "candidate_set_is_not_partner_prediction": true, "candidate_companies": [ "Cadence Design Systems", "Synopsys / Ansys", "Siemens Digital Industries Software", "Dassault Systemes" ], "selection_basis": [ "scarce engineering workflow and tool control", "deterministic or physics-based validation", "high economic cost of design delay or failure", "deep enterprise distribution" ], "supporting_record_ids": [ "SS-AIDT-2026-0016", "SS-CAP-20260930-13C7C0BF7CA0" ], "outcome_observations": [] }, "original_url": "/ai-data-transactions/outlooks/frontier-value-capture/#ss-fvc-ind-2026-001", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "observations": [], "latest_assessment": "unresolved", "latest_assessed_on": null, "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FVC-IND-2026-002", "version": "1.0.0", "kind": "industry_prediction", "original_definition": { "prediction_id": "SS-FVC-IND-2026-002", "status": "unresolved", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "industry_id": "life-sciences-drug-discovery", "industry": "Drug discovery, biotechnology, and clinical-data science", "forecast": "Milestone, royalty, training-run, or shared-service economics should emerge because successful model outputs can influence high-value research decisions and the domain already contains separately monetized data rights.", "confirmation": "At least one new frontier-lab arrangement in this industry discloses Stage 3-4 economics during the horizon.", "invalidation": "New frontier-lab arrangements remain limited to licenses, seats, or access economics through the horizon.", "confidence": "moderate", "candidate_set_is_not_partner_prediction": true, "candidate_companies": [ "Tempus AI", "Recursion Pharmaceuticals", "Schrodinger", "IQVIA", "Thermo Fisher Scientific" ], "selection_basis": [ "scarce experimental or clinical data", "expensive research decisions", "measurable validation milestones", "existing licensing and co-development precedents" ], "supporting_record_ids": [ "SS-AIDT-2025-0001", "SS-AIDT-2025-0002", "SS-AIDT-2026-0012", "SS-CAP-20260926-73A63A01605C" ], "outcome_observations": [] }, "original_url": "/ai-data-transactions/outlooks/frontier-value-capture/#ss-fvc-ind-2026-002", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "observations": [], "latest_assessment": "unresolved", "latest_assessed_on": null, "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FVC-IND-2026-003", "version": "1.0.0", "kind": "industry_prediction", "original_definition": { "prediction_id": "SS-FVC-IND-2026-003", "status": "unresolved", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "industry_id": "cybersecurity", "industry": "Cybersecurity and managed defense", "forecast": "Outcome-linked structures should become viable where frontier models are embedded in live detection, validation, remediation, and re-testing loops, although liability will slow the move from workflow pricing to shared economics.", "confirmation": "At least one frontier-lab cyber arrangement discloses Stage 3-4 economics tied to managed defense, remediation, incident outcomes, or downstream service revenue.", "invalidation": "Frontier-lab cyber partnerships remain entirely Stage 0-2 through the horizon.", "confidence": "moderate", "candidate_set_is_not_partner_prediction": true, "candidate_companies": [ "Palo Alto Networks", "CrowdStrike", "Fortinet", "Cloudflare", "Microsoft Security" ], "selection_basis": [ "continuously refreshed proprietary threat data", "executable professional workflows", "measurable remediation outcomes", "large recurring enterprise spend" ], "supporting_record_ids": [ "SS-CAP-20260922-2BCDD20B8D7C", "SS-CAP-20260924-7D32DF2DC412" ], "outcome_observations": [] }, "original_url": "/ai-data-transactions/outlooks/frontier-value-capture/#ss-fvc-ind-2026-003", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "observations": [], "latest_assessment": "unresolved", "latest_assessed_on": null, "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FVC-IND-2026-004", "version": "1.0.0", "kind": "industry_prediction", "original_definition": { "prediction_id": "SS-FVC-IND-2026-004", "status": "unresolved", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "industry_id": "financial-professional-workflows", "industry": "Financial information, capital-markets infrastructure, legal, and professional workflows", "forecast": "Frontier labs should move from generic model access toward co-commercialized specialist workflow products, but regulated accountability and incumbent control make Stage 2 more likely before Stage 3-4 economics.", "confirmation": "At least two new frontier-lab specialist workflow arrangements are announced, with at least one disclosing Stage 3-4 economics.", "invalidation": "No new specialist frontier-lab workflow arrangement with downstream economics is found by horizon end.", "confidence": "moderate", "candidate_set_is_not_partner_prediction": true, "candidate_companies": [ "Bloomberg", "LSEG", "Nasdaq", "S&P Global", "FactSet", "Thomson Reuters", "RELX / LexisNexis" ], "selection_basis": [ "high-value proprietary information", "specialist workflow ownership", "entitlement and compliance infrastructure", "large professional customer bases" ], "supporting_record_ids": [ "SS-CAP-20260927-1111040F4978", "SS-CAP-20260929-538A8637DB46", "SS-CAP-20260929-92F337B317BB", "SS-CAP-20260930-39F057FD87F1" ], "outcome_observations": [] }, "original_url": "/ai-data-transactions/outlooks/frontier-value-capture/#ss-fvc-ind-2026-004", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "observations": [], "latest_assessment": "unresolved", "latest_assessed_on": null, "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FVC-IND-2026-005", "version": "1.0.0", "kind": "industry_prediction", "original_definition": { "prediction_id": "SS-FVC-IND-2026-005", "status": "unresolved", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "industry_id": "industrial-energy-operations", "industry": "Industrial operations, energy, equipment, and process optimization", "forecast": "The value-capture gap is structurally large because small improvements in uptime, yield, maintenance, or process design can be economically material, but fragmented systems and safety constraints will make observable deals slower to emerge.", "confirmation": "At least one new Stage 3-4 frontier-lab arrangement tied to industrial yield, maintenance, process optimization, or energy operations is announced during the horizon.", "invalidation": "No qualifying Stage 3-4 frontier-lab arrangement is found after a documented horizon-end sector search.", "confidence": "low_moderate", "candidate_set_is_not_partner_prediction": true, "candidate_companies": [ "Siemens", "Honeywell", "Rockwell Automation", "Caterpillar", "SLB", "Schneider Electric" ], "selection_basis": [ "high-cost operational outcomes", "renewable sensor and intervention histories", "control of executable industrial workflows", "strong customer distribution" ], "supporting_record_ids": [ "SS-AIDT-2026-0007", "SS-CAP-20260920-18759FE9B4C1" ], "outcome_observations": [] }, "original_url": "/ai-data-transactions/outlooks/frontier-value-capture/#ss-fvc-ind-2026-005", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "observations": [], "latest_assessment": "unresolved", "latest_assessed_on": null, "follow_up_state": "within_observation_window" }, { "forecast_id": "SS-FVC-IND-2026-006", "version": "1.0.0", "kind": "industry_prediction", "original_definition": { "prediction_id": "SS-FVC-IND-2026-006", "status": "unresolved", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "industry_id": "healthcare-operations", "industry": "Healthcare operations and clinical workflow", "forecast": "Frontier-model value capture should advance first through governed workflow products and later through outcome-linked economics because the economic surplus is large but reimbursement, safety, privacy, and clinical accountability make direct outcome sharing harder.", "confirmation": "At least two new frontier-lab healthcare workflow arrangements are announced and at least one moves beyond access or seat economics into Stage 3-4.", "invalidation": "No frontier-lab healthcare arrangement reaches Stage 3-4 during the horizon.", "confidence": "low_moderate", "candidate_set_is_not_partner_prediction": true, "candidate_companies": [ "Epic", "Oracle Health", "Cognizant TriZetto", "Optum", "athenahealth" ], "selection_basis": [ "large measurable administrative and clinical workflow cost", "deep proprietary longitudinal records", "embedded system-of-record distribution", "high regulatory and liability friction" ], "supporting_record_ids": [ "SS-CAP-20260930-06BC81AFAF68", "SS-CAP-20260930-B4467D37D033" ], "outcome_observations": [] }, "original_url": "/ai-data-transactions/outlooks/frontier-value-capture/#ss-fvc-ind-2026-006", "issued_on": "2026-10-02", "horizon_start": "2026-10-03", "horizon_end": "2027-10-02", "observations": [], "latest_assessment": "unresolved", "latest_assessed_on": null, "follow_up_state": "within_observation_window" } ], "limitations": [ "Assessment status is taken from the latest published observation, not inferred from newer headlines.", "An elapsed horizon requests assessment; it does not mark the forecast true or false.", "This register creates no hit rate, score, or new forecast.", "Industry predictions inherit the published parent horizon; their original criteria are preserved verbatim." ] }